Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-08 5:02 pm Unchanged | 2023-03-08 | 13G | Prometheus Biosciences, Inc. RXDX | Cedars Sinai Intellectual Property Co | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-16 6:07 pm Unchanged | 2023-02-16 | 13G | Prometheus Biosciences, Inc. RXDX | Cedars Sinai Intellectual Property Co | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:27 pm Unchanged | 2023-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 3:01 pm Unchanged | 2023-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 2:35 pm Unchanged | 2023-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 1:58 pm Unchanged | 2023-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 10:06 am Unchanged | 2023-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | RTW INVESTMENTS LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-03 12:09 pm Unchanged | 2023-02-03 | 13G | Prometheus Biosciences, Inc. RXDX | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-06-06 5:50 pm Unchanged | 2022-06-06 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-09 3:23 pm Unchanged | 2022-05-09 | 13G | Prometheus Biosciences, Inc. RXDX | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:48 pm Unchanged | 2022-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:35 pm Unchanged | 2022-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 3:15 pm Unchanged | 2022-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 11:35 am Unchanged | 2022-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 10:20 am Unchanged | 2022-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | Nestle Health Science US Holdings Inc. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-11 12:47 pm Unchanged | 2022-02-11 | 13G | Prometheus Biosciences, Inc. RXDX | Cedars Sinai Intellectual Property Co | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-04 4:12 pm Unchanged | 2022-02-04 | 13G | Prometheus Biosciences, Inc. RXDX | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |